Novartis AG is 136.1x more valuable than HUTCHMED (China) Ltd by market capitalization ($283.13 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HCM | NVS |
|---|---|---|
| Market cap | $2.08 B | $283.13 B |
| US-listed rank | #2073 | #47 |
| Revenue (latest FY) | $548.51M | - |
| Net income (latest FY) | $456.91M | - |
| Net margin | 83.3% | - |
| P/E (trailing FY) | 4.6 | - |
| SEC filings | 589 | 947 |
Novartis AG is 136.1x more valuable than HUTCHMED (China) Ltd by market capitalization ($283.13 B vs $2.08 B).
Full pages: HUTCHMED (China) Ltd and Novartis AG, or browse the full rankings.